Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Jonsson Comprehensive Cancer Center
University of Nebraska
Adela, Inc
Cancer Research UK
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Colorado, Denver
Washington University School of Medicine
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
National Cancer Institute (NCI)
Stanford University
Taproot Health
Cedars-Sinai Medical Center
Cancer Support Community, Research and Training Institute, Philadelphia
Eastern Cooperative Oncology Group
Celgene
CureOne
National Institutes of Health Clinical Center (CC)
Butler Hospital
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Fox Chase Cancer Center
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Novacea